A Staged Phase I/II Study, to Assess Safety, Efficacy and Immunogenicity of a New Hepatitis C Prophylactic Vaccine Based on Sequential Use of AdCh3NSmut1 and MVA-NSmut
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 17 Nov 2016 Planned End Date changed from 1 Oct 2017 to 1 Jul 2018.
- 17 Nov 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Jul 2018.